News Headline Summary

FDA approves RAVICTI which is marketed by Hyperion Therapeutics (HPTX)

Reaction details:

- HPTX shares moved 4.73% to the upside in reaction; last trade at USD 16.13.
UPDATE: In the 2 mins following the news Co.'s shares were halted.

Print 17:18, 01 Feb 2013 - US Equities - Source: Newswires